Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.
Research Interests

Papers共 14 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
A Phase I Study of FHD-609, a Heterobifunctional Degrader of Bromodomain-Containing Protein 9, in Patients with Advanced Synovial Sarcoma or SMARCB1-Deficient Tumors
J Andrew Livingston,Jean-Yves Blay,Jonathan Trent,Claudia Valverde,Mark Agulnik,Mrinal Gounder,Axel Le Cesne,Meredith McKean,Michael J Wagner,Silvia Stacchiotti,Samuel Agresta, Alfonso Quintás-Cardama, Sarah A Reilly, Kathleen Healy,Denice Hickman, Tina Zhao, Alex Ballesteros-Perez, Alexis Khalil, Michael P Collins,Jessica Piel, Kim Horrigan, Ariel Lefkovith, Scott Innis,Alexander J Lazar,Gregory M Cote,Andrew J Wagner
Clinical cancer research an official journal of the American Association for Cancer Researchno. 4 (2025): 628-638
Cited0Views0WOSBibtex
0
0
A Phase I Study of FHD-286, a Dual BRG1/BRM (SMARCA4/SMARCA2) Inhibitor, in Patients with Advanced Myeloid Malignancies
Courtney D DiNardo, Amir T Fathi,Ashwin Kishtagari,Kapil N Bhalla, Alfonso Quintás-Cardama, Sarah A Reilly, Caroline Almon, Caitlin Patriquin, Salah Nabhan, Kathleen Healy,Denice Hickman, Michael P Collins, Alexis Khalil, Dillon Corrigan, Tina Zhao,Jessica Piel, Kelly Lyons, Kim Horrigan, Virna Schuck, Paul Martin, GiNell Elliott,David L Lahr, Mia Bosinger, Katie D'Aco, Gromoslaw Aleksander Smolen, Martin Hentemann,Sanam Loghavi,Samuel Agresta,Michael R Savona, Eytan M Stein
Clinical cancer research an official journal of the American Association for Cancer Researchno. 12 (2025): 2327-2338
Cited0Views0WOSBibtex
0
0
Load More
Author Statistics
  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn